D-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study.
about
Ribose Supplementation Alone or with Elevated Creatine Does Not Preserve High Energy Nucleotides or Cardiac Function in the Failing Mouse Heart.D-ribose aids heart failure patients with preserved ejection fraction and diastolic dysfunction: a pilot study.Metabolic modulators for chronic cardiac ischemia.Ribose Accelerates Gut Motility and Suppresses Mouse Body Weight GainingAssessment of Hematological and Biochemical parameters with extended D-Ribose ingestion.Quality of life assessment in heart failure interventions: a 10-year (1996-2005) review.Potential of metabolic agents as adjunct therapies in heart failure.Efficacy of metabolic modulators in ischemic heart disease: an overview.Nutritional and micronutrient determinants of idiopathic dilated cardiomyopathy: diagnostic and therapeutic implications.Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults.Cellular protection during oxidative stress: a potential role for D-ribose and antioxidants.Ribose in the heart.Supplementation of creatine and ribose prevents apoptosis in ischemic cardiomyocytes.Modulation of intracellular ATP determines adenosine release and functional outcome in response to metabolic stress in rat hippocampal slices and cerebellar granule cells.Benefit of ribose in a patient with fibromyalgia.The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease.Evaluation of α-D-ribofuranose (D-ribose) toxicity after intravenous administration to rabbits.Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose.Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy in rats.Potential Clinical Benefits of D-ribose in Ischemic Cardiovascular Disease.
P2860
Q34792221-8B1DD2DA-50F1-415E-9E0B-F50E960A8395Q35629938-C2807C33-0EC9-47B0-A54E-CCE68AA9BB8CQ36355273-1CB33C5C-768F-410B-93CC-E3579BCF9AB9Q36911092-24A639DA-4B7C-4D15-BBE6-9ECEBC86A7FBQ36942512-5F4A5CB2-DD9F-4C9E-AD3D-DF832754F1CAQ36966553-62AFAB93-CF81-4897-86B6-A8FCCBD6C7F2Q37608595-C4505D87-048B-4B9B-8AAC-2878E927FCC9Q37850633-6D1528E2-FC4D-42E5-B688-7BFEA2E7BD66Q37935777-37E67973-BDA0-4631-859A-31883A067CF3Q37993133-4FAD8CF0-E26C-464F-AE91-4A0179B26FBEQ38034566-76250168-5CAE-4ECB-A638-27004444ADF7Q42720374-DE7A95A7-8575-481A-8914-03EB08394FAFQ42759674-42EB9A32-5AB7-4040-B455-192C4B2DE88FQ44441170-80B4C727-9F24-4657-B58C-68D2741AC2FBQ45146735-E0DF46E3-0BD4-491C-A581-AE70DCCC3895Q50115527-DDA6D672-CA26-4C28-9644-11F4F5271D63Q51367726-43BD3CDC-6A84-41E3-86C4-D3A2FAC15EC3Q52335223-697BC24D-3632-40F9-BA94-F164222388A5Q54067131-3228482E-57AA-4B32-87FC-C965803FAC80Q55265606-5266B0A3-57D3-4379-87BE-654C5D8643FD
P2860
D-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
D-Ribose improves diastolic fu ...... prospective feasibility study.
@en
D-Ribose improves diastolic fu ...... prospective feasibility study.
@nl
type
label
D-Ribose improves diastolic fu ...... prospective feasibility study.
@en
D-Ribose improves diastolic fu ...... prospective feasibility study.
@nl
prefLabel
D-Ribose improves diastolic fu ...... prospective feasibility study.
@en
D-Ribose improves diastolic fu ...... prospective feasibility study.
@nl
P2093
P2860
P921
P1476
D-Ribose improves diastolic fu ...... prospective feasibility study.
@en
P2093
Berndt Lüderitz
Dean MacCarter
Heyder Omran
John St Cyr
Stefan Illien
P2860
P304
P356
10.1016/S1388-9842(03)00060-6
P577
2003-10-01T00:00:00Z